Kodiak Sciences, Inc. (KOD)
39.93
-1.08
(-2.63%)
USD |
NASDAQ |
May 11, 16:00
39.93
0.00 (0.00%)
After-Hours: 19:34
Kodiak Sciences Shareholders Equity (Quarterly) : 112.10M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 346.18M |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Madrigal Pharmaceuticals, Inc. | 543.45M |
| ADMA Biologics, Inc. | 390.32M |
| Revolution Medicines, Inc. | 1.500B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 306.01M |
| Total Liabilities (Quarterly) | 193.90M |
| Debt to Equity Ratio | 1.392 |
| Current Ratio | 3.535 |
| Net Debt Paydown Yield | 0.12% |